I-Myopia (okanye ukubona kufutshane) ebantwaneni yimeko yombono exhaphake kakhulu. Kuqikelelwa ukuba ukuxhaphaka kwehlabathi lonke kuya kufikelela malunga ne-50% ngonyaka we-2050 malunga ne-9.8% yabantu abachatshazelwa yi-myopia ephezulu. Ukuba abanyangwanga, abantwana abane-myopia ephezulu baba nemingcipheko eyongeziweyo yokuphazamiseka kwamehlo okumandundu okufana ne-retinal detachment, i-myopic maculopathy, i-glaucoma, i-cataract, njl njl. Iilensi ze-single-vision spectacle (SVL) ezazisetyenziswa ngokwemveli zilungisa i-myopia kodwa zingacothi ukuqhubeka kwayo. Iinzame ezibhekiselele kulawulo lwe-myopia esekwe kumboniso zathatha ubume obubambekayo xa, ngo-2021, uyilo lwenoveli ezimbini zeelensi ezithi. IiLensi zeSpectacle ezineLensi zeAspherical Highly (HAL) kunye neeLensi zeSpectacle ezineLenslet aspherical Slightly Aspherical (SAL), nganye eneelensi zeperipheral azibonisanga ziphumo kwimisebenzi yokubonwayo evavanyiweyo kwaye zifunyenwe zikhuselekile kulawulo lwe-myopia. Uphononongo olulandelayo lubonise ukuba ngelixa zombini i-HAL kunye ne-SAL zinciphisa izinga lokuqhubeka kwe-myopia kunye ne-axial elongation, i-HAL inolawulo olungcono lwe-myopia. Kwakhona, ukusetyenziswa kwexesha elide kwe-HAL spectacles kunciphisa izehlo ze-myopia ephezulu kwaye kunokuchaphazela ukutyumba kwe-retinal kunye ne-symmetry. Ngokusekwe kuvavanyo lobungqina, i-US FDA inike isigunyaziso sentengiso nge-25 kaSeptemba 2025 kwi-Essilor Stellest iilensi zeglasi zabantwana abaneminyaka emi-6 ukuya kweli-12 ubudala. Isixhobo siquka "iilensi zokubukela ezineelensi ze-aspherical". Iilensi zinendawo ecacileyo eyi-9 mm yedayamitha embindini, ejikelezwe ngamakhonkco eelensi zeperipheral (amachaphaza amancinane, aphakanyisiweyo) kwenye ilensi iphela. Iilensi zeperipheral zibonelela nge-peripheral light defocus, ezinceda ukucothisa ukuqhubeka kwe-myopia. Iilensi zeglasi ye-Essilor Stellest ziilensi zeglasi zamehlo zokuqala eziboniswe ukucotha ukuqhubeka kwe-myopia ebantwaneni.
I-Essilor Stellest eyeglass lens, eyenzelwe ukulungisa nokulawula ukuqhubeka kwe-myopia kubantwana abaneminyaka eyi-6 ukuya kwe-12 ubudala ifumene isigunyaziso sentengiso yi-US FDA ngomhla we-25 Septemba 2025. Ugunyaziso lusekwe kuvavanyo lweminyaka emibini yedatha evela kulingo lwezonyango olubonise iilensi ze-Essilor Stellest zeglasi zamehlo zacotha ukulawulwa kwe-myopia kwi-single lense. Yanikwa ukuchongwa kwesiXhobo seBreakthrough ngaphambili nge-30 ka-Epreli 2021 ukukhawulezisa uphuhliso kunye nophononongo.
Iilensi zeglasi ye-Essilor Stellest ziilensi zokubukela ezine "aspherical lenslets". Iilensi zinendawo ecacileyo eyi-9 mm yedayamitha embindini, ejikelezwe ngamakhonkco eelensi zeperipheral (amachaphaza amancinane, aphakanyisiweyo) kwenye ilensi iphela.
Iilensi zeperipheral zibonelela nge-peripheral light defocus, enokunceda ukucothisa ukuqhubeka kwe-myopia ebantwaneni. Le yindlela i-Essilor Stellest yokubona i-lens iphucula ngayo inoveli kwiilensi eziqhelekileyo ezisetyenziselwa ukulungisa i-myopia.
I-Myopia ebantwaneni-inkxalabo ebalulekileyo yempilo yoluntu yehlabathi
I-Myopia (ekwaziwa ngokuba ngumbono okufutshane okanye ukubona okufutshane) yimeko eqhelekileyo yokubona apho izinto ezikufutshane zinokubonwa ngokucacileyo, kodwa izinto ezikude zibonakala zimfiliba. Iilensi zendalo kunye nezinye iindawo zamehlo zichaphazeleka ngendlela yokuba umfanekiso wezinto ugxile phambi kweretina endaweni yeretina. Yimeko yombono exhaphake kakhulu, ngakumbi phakathi kwabantu abancinci abaneminyaka eyi-10 ukuya kwengama-25 ubudala, ethe yathatha isikali senkxalabo yempilo yoluntu jikelele. Amanye amazwe aseAsia achaphazeleka kakhulu. E-China, malunga ne-47% yabantu bebonke baye baphathwa yi-myopia ngo-2020. Ukuxhaphaka kwabantwana kunye nolutsha lwalungama-53.6% kwaye ukuxhaphaka ngokubanzi kwabafundi beekholeji kudlule i-90%. Isimo esifanayo sibonwa kumazwe aseMpuma nakuMzantsi Asia. E-USA, ichaphazela malunga ne-40% yabemi apho izinga lokuxhaphaka phakathi kwabantwana kunye nolutsha lusanda ngokukhawuleza. Phakathi kwabamhlophe baseYurophu ukuxhaphaka ngokubanzi malunga ne-4.7% kunye ne-13.4% eNorway, i-11.4% eJamani, kunye ne-19.9% e-Ireland. Ukuxhaphaka kusezantsi e-Afrika. Xa kujongwa le meko ikhoyo ngoku, kuqikelelwa ukuba ukuxhaphaka kwehlabathi lonke kuya kufikelela malunga ne-50% ngonyaka ka-2050 kunye nabantu abamalunga ne-9.8% abachatshazelwa yi-myopia ephezulu. Ukuba ayiphathwa, abantu abane-myopia ephezulu baqhuba imingcipheko eyongeziweyo yeengxaki zombono (i-retinal detachment, i-myopic maculopathy, i-glaucoma, kunye ne-cataracts) kamva ebomini. Ngokubhekiselele kwimeko yokuphindaphinda kwesifo, imodeli ebanzi yothintelo kunye nolawulo lwe-myopia ebantwaneni nakulutsha lujongwe njengento eyimfuneko. Ulawulo lwe-myopia olusekwe kwi-Spectacle yeyona ndlela iphambili.
Uyilo lwenoveli yeelensi zembonakalo yolawulo lwe-myopia
Iinzame ezibhekiselele kulawulo lwe-myopia esekwe kumboniso zaqala ukuthatha ubume obubambekayo ngopapasho (ngo-2021) lweziphumo zovavanyo loyilo lweelensi ezimbini zeenoveli ngeziphumo zazo kwimisebenzi yokubonwayo kubantu abadala abaqhelekileyo. Uyilo ngalunye lwaluneelensi zeperipheral. I-lens yombono omnye (SVL) isetyenziswe njengolawulo. Uyilo olubini ol. IiLensi zeSpectacle ezineLensi zeAspherical Highly (HAL) kunye neeLensi zeSpectacle ezineLenslet aspherical Slightly Aspherical (SAL) zifunyenwe zikhuselekile kulawulo lwe-myopia njengoko zingabonakalisi siphumo kwimisebenzi yokubonwayo evavanyiweyo.
Kunyaka olandelayo ngo-2022, iziphumo zolingo lwezonyango oluqhutywe kubantwana abali-157 lokuvavanya ukusebenza kweelensi zokubukela ezineelensi ze-aspherical aspherical (HAL) kunye neelensi ezingathi zi-aspherical (SAL) vis-a-vis zemveli zelensi zombono omnye (SVL) ekulawuleni ukuqhubeka kwe-myopia ethatha iminyaka emi-2 zapapashwa. Uphononongo lubonise ukuba ngelixa zombini i-HAL kunye ne-SAL zinciphisa izinga lokunyuka kwe-myopia kunye ne-axial elongation, i-asphericity ephezulu ye-lenslets ilawula i-myopia ngokufanelekileyo, oko kukuthi, i-HAL inxulunyaniswa nokusebenza kakuhle kokulawula i-myopia. Oku kuzise uyilo lwe-HAL kwindawo ebonakalayo.
IiLensi zeSpectacle ezineLensi zeAspherical Highly (HAL) zikhusela i-myopia
Uphononongo olongezelelekileyo lweminyaka emi-5 (eyapapashwa nge-5 kuMatshi ka-2025) kubathathi-nxaxheba abangama-43 kwiqela lokuqala le-HAL lubonise ukuba ukusetyenziswa kweelensi ze-spectacle ezine-aspherical lenslets (HAL) zithintele ukulingana kweminyaka emi-3 yokuqhubekeka kwe-myopia kunye nobude be-axial (AL) ngokufanelekileyo. Kwakhona, ukusetyenziswa kwexesha elide kwe-HAL spectacles kunciphisa iziganeko ze-myopia ephezulu. Olunye uphononongo lwakutsha nje (olupapashwe nge-29 kaMatshi ngo-2025) luphande iziphumo ze-HAL kubude beso le-peripheral (PEL) kunye ne-peripheral refraction (PR) ebantwaneni bafumanise ukuba ukutshintshela okanye ukuqhubeka nokunxiba i-HAL kunokucothisa umbindi kunye nobude bexeshana. Ukunxiba iilensi zokubukela ezineelensi ezizii-aspherical eziphezulu (HAL) kunokuba nefuthe ekunyukeni kweretina kunye nokulingana.
I-“Spectacle Lens with Aspherical Lenslets” ifumana isigunyaziso sentengiso se-FDA
Ngokusekwe kuvavanyo lweminyaka emibini yedatha evela kulingo olubonise iilensi zeglasi ye-Essilor Stellest yacotha ukuqhubeka kwe-myopia (xa kuthelekiswa neelensi zokulawula umbono omnye), i-US FDA inike isigunyaziso sentengiso nge-25 kaSeptemba 2025 kwiilensi zeglasi ze-Essilor Stellest eziyilelwe ukulungisa nokulawula ukuqhubeka kwe-myopia kubantwana abaneminyaka eyi-6 ukuya kwe-12. Yilensi yeglasi yokuqala eboniswe ukucotha ukuqhubela phambili kwe-myopia ebantwaneni. Yanikwa igama elithi "isixhobo sokuphumelela" kwangoko nge-30 ka-Epreli 2021 ukukhawulezisa uphuhliso kunye nophononongo.
Ukuza kuthi ga ngoku, i-lens yoqhagamshelwano yayikuphela kwesixhobo esivunyiweyo sokulawula ukuqhubeka kwe-myopia kubantwana abakwiminyaka eyi-8-12 yeqela. Isanda kuvunywa Iilensi zeglasi ye-Essilor Stellest nikeza ukhetho lwabantwana abakwiminyaka eyi-6-7 yeqela. Ikwabonelela ngenketho yomngcipheko ophantsi kubo bonke abantwana abafumana kunzima ukunxiba iilensi zoqhagamshelwano ngenxa yeziganeko ezimbi ezifana nosulelo.
***
Iingxelo:
- UZhao, L., kunye nabanye. Ukuxhaphaka kunye nomngcipheko we-myopia phakathi kwabantwana kunye nolutsha olukwishumi elivisayo e-Hangzhou. Sci Rep 14, 24615 (2024). DOI: https://doi.org/10.1038/s41598-024-73388-7
- Gao Y., okqhubekayo 2021. Impembelelo yeelensi ze-spectacle zokulawula i-myopia kwimisebenzi ebonakalayo. Ipapashwe: 16 Septemba 2021. DOI: https://doi.org/10.1111/opo.12878
- Bao J., et al.2022. IiLensi zeSpectacle ezineLenslet zeAspherical for Myopia Control vs iiLensi zoMbono omnye woMbono omnye: Uvavanyo lweklinikhi olungaQhetywanga. JAMA Ophthalmol Ipapashwe: 31 Matshi 2022;140;(5):472-478. DOI: https://doi.org/10.1001/jamaophthalmol.2022.0401
- Li, X., et al 2025. I-Myopia yokulawula ukusebenza kakuhle kwee-lens ze-spectacle ezine-aspherical lenslets eziphezulu: iziphumo ze-5-year-up-up study-update. Iliso kunye ne-Vis 12, 10 (2025). Ipapashwe: 05 Matshi 2025. DOI: https://doi.org/10.1186/s40662-025-00427-3
- U-Huang Y., et al 2025. Impembelelo yeelensi ze-spectacle ezine-aspherical lenslets eziphezulu kwiinguqu kubude beso le-peripheral kunye ne-asymmetry. Ipapashwe: 29 Matshi 2025. DOI: https://doi.org/10.1111/opo.13500
- Ulingo lwezonyango – iLens Stellest Wear kwi-Adult Progressing Myopes (SWAP). Ifumaneka e https://clinicaltrials.gov/study/NCT06520124
- Ukukhutshwa kweendaba ze-FDA. I-FDA igunyazisa ukuThengiswa kweeLensi zeglasi yamehlo yokuQala ukuya kuNqulo olucothayo lweMyopia yabantwana. 25 Septemba 2025. Iyafumaneka e https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-first-eyeglass-lenses-slow-progression-pediatric-myopia
- Essilor. Lungisa umbono wakho - Stellest. Ifumaneka e https://www.essilor.com/uk-en/products/stellest/
***
***
Inqaku elinxulumene nalo
- 'I-Autofocals', iPrototype yeglasi yokulungisa iPresbyopia (Ilahleko yoMbono okufutshane) (4 Julayi 2019)
- Iliso le-Bionic: Isithembiso sombono wezigulane ezinomonakalo we-Retinal kunye ne-Optic Nerve (15 February 2018)
***
 in children is a highly prevalent vision condition. It is estimated that the worldwide prevalence will reach about 50% by the year 2050 with about 9.8% people affected by high myopia. If untreated, children with high myopia run increased risks of serious eye disorders like retinal detachment, myopic maculopathy, glaucoma, cataracts, etc later in life. Traditionally used single-vision spectacle lenses (SVL) correct myopia but do not slow its progression. The efforts towards spectacle-based myopia control took concrete shape when, in 2021, two novel lens designs viz. Spectacle Lenses with Highly Aspherical Lenslets (HAL) and Spectacle Lenses with Slightly Aspherical Lenslets (SAL), each with peripheral lenslets showed no effect on tested visual functions and were found to be safe for myopia control. Subsequent studies showed that while both HAL and SAL reduced the rate of myopia progression and axial elongation, HAL has better myopia control efficacy. Also, long-term use of HAL spectacles reduced the incidence of high myopia and could impact retinal steepness and symmetry. Based on evaluation of evidence, US FDA granted marketing authorisation on 25 September 2025 to Essilor Stellest eyeglass lenses for children 6 to 12 years old. The device comprises of “spectacle lenses with aspherical lenslets”. Lenses have a clear 9 mm diameter area in the centre, which is surrounded by rings of peripheral lenslets (tiny, raised dots) on the rest of the lens. The peripheral lenslets provide peripheral light defocus, which help to slow the progression of myopia. Essilor Stellest eyeglass lenses are the first eyeglass lenses shown to slow progression of myopia in children.){kind=link}